作者: Ulrich Martin , Ruth Olmer
DOI: 10.1007/978-94-017-8032-2_5
关键词:
摘要: The conversion of somatic cells into so called induced pluripotent stem (iPSCs) is generally considered as major breakthrough in cell research, and cardiomyocytes derived from human iPS are promising source for disease modelling, drug screening safety pharmacology, future therapeutic applications.